These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 38904798

  • 1. Development and validation of individualized tacrolimus dosing software for Chinese pediatric liver transplantation patients: a population pharmacokinetic approach.
    Yang S, Wei J, Pan X, Li Z, Zhang X, Li Z, Dong X, Hua Z, Li X.
    Eur J Clin Pharmacol; 2024 Sep; 80(9):1409-1420. PubMed ID: 38904798
    [Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation.
    Yang JW, Liao SS, Zhu LQ, Zhao Y, Zhang Y, Sun XY, Rao W, Qu W, Li WZ, Sun LY.
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):75-83. PubMed ID: 25207550
    [Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ, Tham LS, Holmes MJ, Aw M, Quak SH, Lee KH, Lim SG, Prabhakaran K, Chan SY, Ho PC.
    Clin Pharmacokinet; 2006 Jan; 45(1):59-75. PubMed ID: 16430311
    [Abstract] [Full Text] [Related]

  • 4. Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients.
    Lee JY, Hahn HJ, Son IJ, Suh KS, Yi NJ, Oh JM, Shin WG.
    Pharmacotherapy; 2006 Aug; 26(8):1069-77. PubMed ID: 16863483
    [Abstract] [Full Text] [Related]

  • 5. Impact of Donor and Recipient CYP3A5*3 Genotype on Tacrolimus Population Pharmacokinetics in Chinese Adult Liver Transplant Recipients.
    Shao J, Wang C, Fu P, Chen F, Zhang Y, Wei J.
    Ann Pharmacother; 2020 Jul; 54(7):652-661. PubMed ID: 31888346
    [Abstract] [Full Text] [Related]

  • 6. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
    Wallin JE, Bergstrand M, Wilczek HE, Nydert PS, Karlsson MO, Staatz CE.
    Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
    [Abstract] [Full Text] [Related]

  • 7. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese pediatric hematopoietic stem cell transplantation patients.
    Wang D, Chen X, Xu H, Li Z.
    Xenobiotica; 2020 Feb; 50(2):178-185. PubMed ID: 30938547
    [Abstract] [Full Text] [Related]

  • 8. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.
    Sam WJ, Aw M, Quak SH, Lim SM, Charles BG, Chan SY, Ho PC.
    Br J Clin Pharmacol; 2000 Dec; 50(6):531-41. PubMed ID: 11136292
    [Abstract] [Full Text] [Related]

  • 9. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients.
    Chen B, Shi HQ, Liu XX, Zhang WX, Lu JQ, Xu BM, Chen H.
    J Clin Pharm Ther; 2017 Dec; 42(6):679-688. PubMed ID: 28833329
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Population pharmacokinetics of tacrolimus in Chinese renal transplant patients].
    Zhang GM, Li L, Chen WQ, Bi SS, Liu X, Zhang XL, Lu W.
    Yao Xue Xue Bao; 2008 Jul; 43(7):695-701. PubMed ID: 18819472
    [Abstract] [Full Text] [Related]

  • 14. Toward a robust tool for pharmacokinetic-based personalization of treatment with tacrolimus in solid organ transplantation: A model-based meta-analysis approach.
    Nanga TM, Doan TTP, Marquet P, Musuamba FT.
    Br J Clin Pharmacol; 2019 Dec; 85(12):2793-2823. PubMed ID: 31471970
    [Abstract] [Full Text] [Related]

  • 15. Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants.
    Staatz CE, Taylor PJ, Lynch SV, Willis C, Charles BG, Tett SE.
    Transplantation; 2001 Sep 27; 72(6):1056-61. PubMed ID: 11579300
    [Abstract] [Full Text] [Related]

  • 16. Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation.
    Musuamba FT, Guy-Viterbo V, Reding R, Verbeeck RK, Wallemacq P.
    Ther Drug Monit; 2014 Feb 27; 36(1):54-61. PubMed ID: 24081207
    [Abstract] [Full Text] [Related]

  • 17. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
    Staatz CE, Willis C, Taylor PJ, Lynch SV, Tett SE.
    Liver Transpl; 2003 Feb 27; 9(2):130-7. PubMed ID: 12548506
    [Abstract] [Full Text] [Related]

  • 18. A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.
    Andrews LM, Hesselink DA, van Gelder T, Koch BCP, Cornelissen EAM, Brüggemann RJM, van Schaik RHN, de Wildt SN, Cransberg K, de Winter BCM.
    Clin Pharmacokinet; 2018 Apr 27; 57(4):475-489. PubMed ID: 28681225
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients.
    Zhang XQ, Wang ZW, Fan JW, Li YP, Jiao Z, Gao JW, Peng ZH, Liu GL.
    Ther Drug Monit; 2012 Apr 27; 34(2):126-33. PubMed ID: 22377746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.